Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Wave Life Sciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 4 filings
- 4 insiders, $135.1K in total
- Insiders trading
- 4
- Net value
- −$135.1K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Wave Life Sciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wagner Heidi L | Director | 44,930 | Aug 13, 2026 | 2 |
| Rawcliffe Adrian | Director | 0 | Aug 13, 2026 | 3 |
| Takanashi Ken | Director | 20,079 | Aug 13, 2026 | 2 |
| Tan Aik Na | Director | 24,968 | Aug 13, 2026 | 2 |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 26,975,505Indirect | Mar 30, 2026 | 2 |
| Ra Capital Management, L.P. | Director, 10% Owner | 26,975,505Indirect | Mar 30, 2026 | 2 |
| Kolchinsky Peter | Director, 10% Owner | 26,975,505Indirect | Mar 30, 2026 | 2 |
| Shah Rajeev M. | Director, 10% Owner | 26,975,505Indirect | Mar 30, 2026 | 2 |
| Francis Chris | See Remarks | 61,867 | Feb 27, 2026 | 4 |
| Vargeese Chandra | See Remarks | 408,246 | Feb 11, 2026 | 1 |
| Bolno Paul | President and CEO | 275,520 | Feb 11, 2026 | 1 |
| Moran Kyle | Chief Financial Officer | 134,385 | Feb 11, 2026 | 2 |
| GlaxoSmithKline PLC | 10% Owner | 18,245,691Indirect | Dec 15, 2025 | 1 |
| Corrigan Mark | Director | 28,815 | Dec 10, 2025 | 1 |
| Henry Christian O | Director | 12,700 | Dec 10, 2025 | 1 |
| Verdine Gregory L. | Director | 275,217 | Dec 10, 2025 | 1 |
| Panzara Michael A. | See Remarks | 109,103 | Jul 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Francis ChrisSee Remarks | SSale | −1.88K | $13.45 | −$25.3K | −3.0%61.9K after | |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Bolno PaulPresident and CEO | SSale | −10.5K | $13.45 | −$141.0K | −3.7%275.5K after | |
| Feb 11, 2026 (view filing) | Feb 9 | 2 days | Moran KyleChief Financial Officer | SSale | −3.59K | $13.45 | −$48.3K | −2.6%134.4K after | |
| Feb 27, 2026 (view filing) | Feb 26 | 1 day | Francis ChrisSee Remarks | SSale | −33.2K | $15.05 | −$499.5K | −34.9%61.9K after | 2 lots10b5-1 |
| Mar 30, 2026 (view filing)8:30 PM ET | Mar 26-30 | 4 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | PPurchase | +8.77M | $6.23 | +$54.6M | +48.2%27.0M after | 4 lots |
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 11 | 2 days | Tan Aik NaDirector | SSale | −432 | $6.01 | −$2.60K | −1.7%25.0K after | 10b5-1 |
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 11 | 2 days | Takanashi KenDirector | SSale | −3.86K | $6.01 | −$23.2K | −16.1%20.1K after | 10b5-1 |
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 12 | 1 day | Rawcliffe AdrianDirector | SSale | −12.7K | $5.29 | −$67.2K | −100.0%0 after | 10b5-1 |
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 11 | 2 days | Wagner Heidi LDirector | SSale | −7.00K | $6.01 | −$42.1K | −13.5%44.9K after | 10b5-1 |